| 000 | 01364 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514050701.0 | ||
| 264 | 0 | _c20021030 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJM200210243471719 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarr, Andrew | |
| 245 | 0 | 0 |
_aFumagillin for intestinal microsporidiosis. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cOct 2002 |
||
| 300 |
_a1381; author reply 1381 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aCyclohexanes |
| 650 | 0 | 4 | _aEnterocytozoon |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xtherapeutic use |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aIntestinal Diseases, Parasitic _xdrug therapy |
| 650 | 0 | 4 |
_aMicrosporidiosis _xdrug therapy |
| 650 | 0 | 4 | _aSesquiterpenes |
| 700 | 1 | _aCooper, David A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 347 _gno. 17 _gp. 1381; author reply 1381 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM200210243471719 _zAvailable from publisher's website |
| 999 |
_c12205915 _d12205915 |
||